Stocks and Investing
Stocks and Investing
Mon, November 7, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Eric Coldwell Maintained (CAH) at Hold with Increased Target to $82 on, Nov 7th, 2022
Eric Coldwell of Baird, Maintained "Cardinal Health, Inc." (CAH) at Hold with Increased Target from $74 to $82 on, Nov 7th, 2022.
Eric has made no other calls on CAH in the last 4 months.
There are 5 other peers that have a rating on CAH. Out of the 5 peers that are also analyzing CAH, 3 agree with Eric's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Michael Cherny of "B of A Securities" Upgraded from Sell to Hold and Increased Target to $80 on, Friday, November 4th, 2022
- Charles Ryhee of "Cowen & Co." Maintained at Hold with Increased Target to $72 on, Tuesday, August 16th, 2022
- A.J. Rice of "Credit Suisse" Maintained at Hold with Increased Target to $64 on, Friday, August 12th, 2022
These are the ratings of the 2 analyists that currently disagree with Eric
- Kevin Caliendo of "UBS" Maintained at Strong Buy with Increased Target to $78 on, Monday, August 29th, 2022
- Ricky Goldwasser of "Morgan Stanley" Maintained at Buy with Decreased Target to $70 on, Thursday, July 14th, 2022
Contributing Sources